Benzinga · Oct 1, 2026
Guggenheim Maintains Buy on CryoPort, Raises Price Target to $19
Guggenheim analyst Subbu Nambi maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target from $16 to $19.
CY
NASDAQ · CYRX
Cryoport, Inc.
Industrials · Integrated Freight & Logistics
$16.84
Down-$0.51 (-2.94%)
Updated Oct 13, 2026, 4:06 AM
SID Score
7.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 482.65M
- P/E ratio
- 7.15
- Dividend yield
- 0.00%
- 52-week range
- $7.64 – $18.36
- Volume
- 602.23K
- Avg. volume
- 672.11K
Price performance · CYRX
CYRX price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 12, 2026
CYRX closed at $16.84 after 21 trading sessions, up 5.51% for the selected period.
- Last close
- $16.84
- Period change
- +5.51%
- Period low
- $15.96
- Period high
- $18.14
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 12, 2026 | $17.22 | $17.28 | $16.56 | $16.84 | 602.23K |
| Oct 9, 2026 | $16.90 | $17.655 | $16.90 | $17.35 | 479.87K |
| Oct 8, 2026 | $17.20 | $17.42 | $16.645 | $16.90 | 1.21M |
| Oct 7, 2026 | $17.36 | $17.55 | $17.126 | $17.35 | 1.37M |
| Oct 6, 2026 | $18.36 | $18.36 | $17.445 | $17.80 | 1.17M |
| Oct 5, 2026 | $17.30 | $18.24 | $17.30 | $18.14 | 1.05M |
| Oct 2, 2026 | $17.57 | $18.06 | $17.36 | $17.43 | 709.91K |
| Oct 1, 2026 | $17.40 | $17.53 | $17.00 | $17.36 | 1.04M |
| Sep 30, 2026 | $17.38 | $17.59 | $17.25 | $17.40 | 571.6K |
| Sep 29, 2026 | $17.38 | $17.55 | $17.06 | $17.32 | 931.69K |
| Sep 28, 2026 | $17.29 | $17.56 | $17.11 | $17.38 | 732.39K |
| Sep 25, 2026 | $17.36 | $17.585 | $17.215 | $17.41 | 729.94K |
| Sep 24, 2026 | $17.33 | $17.98 | $17.25 | $17.40 | 694.84K |
| Sep 23, 2026 | $17.46 | $17.64 | $16.995 | $17.49 | 568.87K |
| Sep 22, 2026 | $17.79 | $17.85 | $17.40 | $17.57 | 587.96K |
| Sep 21, 2026 | $17.17 | $17.65 | $17.00 | $17.62 | 760.64K |
| Sep 18, 2026 | $16.67 | $17.05 | $16.51 | $17.02 | 856.8K |
| Sep 17, 2026 | $16.80 | $17.12 | $16.55 | $16.78 | 753.47K |
| Sep 16, 2026 | $16.29 | $16.90 | $16.29 | $16.51 | 590.58K |
| Sep 15, 2026 | $15.83 | $16.43 | $15.83 | $16.31 | 688.27K |
| Sep 14, 2026 | $15.39 | $15.98 | $15.39 | $15.96 | 473.61K |
Latest CYRX news
The latest Smart Investors Daily articles mentioning CYRX.
Stock researchCompany · Overview
Company
Market Activity
Research & News
CYRX research
Overview
Company profile and research snapshot.
Company profile
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $13.75
- Implied upside
- —
- Analysts
- 15
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 1, 2026 | Guggenheim | Buy | — |
| Sep 18, 2026 | BTIG | Buy | — |
| Aug 7, 2026 | Guggenheim | Buy | — |
| Aug 7, 2026 | Needham | Buy | — |
| Jul 24, 2026 | BTIG | Buy | — |
News briefing
No generated briefing is available yet.
SeekingAlpha · Sep 25, 2026
Cryoport: Strong Pipeline Of Cell And Gene Therapy Approvals
Cryoport returned to EBITDA profitability in 2Q26, with strong Life Science Services growth and positive operating cash flow. Learn why CYRX stock is a buy.
Benzinga · Sep 18, 2026
BTIG Reiterates Buy on CryoPort, Maintains $25 Price Target
BTIG analyst David Larsen reiterates CryoPort (NASDAQ:CYRX) with a Buy and maintains $25 price target.
Yahoo · Aug 14, 2026
Cryoport (CYRX) Q2 2026 Earnings Call Transcript
CGT services revenue surged 15% as clinical trial support expanded to 779 trials globally.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
